About Us Services Careers FAQ Contact Us 0
Home Medical Devices TB Diagnostics Market Size, Growth & Statistics Report 2033

TB Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Nucleic Acid Testing (NAT), Skin Test / Mantoux Test (TST), Blood Test / Serology Test, SMEAR Microscopy, Cultured-Based Tests, Radiography Tests, Others), By End-User (Hospitals and Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics and Research Facilities) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRMD1557DR
Author : Debashree Bora

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global TB Diagnostics Market Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Nucleic Acid Testing (NAT)
        1. By Value
      3. Skin Test / Mantoux Test (TST)
        1. By Value
      4. Blood Test / Serology Test
        1. By Value
      5. SMEAR Microscopy
        1. By Value
      6. Cultured-Based Tests
        1. By Value
      7. Radiography Tests
        1. By Value
      8. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Physician’s Office Laboratories
        1. By Value
      4. Reference Laboratories
        1. By Value
      5. Academics and Research Facilities
        1. By Value
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Nucleic Acid Testing (NAT)
        1. By Value
      3. Skin Test / Mantoux Test (TST)
        1. By Value
      4. Blood Test / Serology Test
        1. By Value
      5. SMEAR Microscopy
        1. By Value
      6. Cultured-Based Tests
        1. By Value
      7. Radiography Tests
        1. By Value
      8. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Physician’s Office Laboratories
        1. By Value
      4. Reference Laboratories
        1. By Value
      5. Academics and Research Facilities
        1. By Value
    4. U.S.
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Nucleic Acid Testing (NAT)
          1. By Value
        3. Skin Test / Mantoux Test (TST)
          1. By Value
        4. Blood Test / Serology Test
          1. By Value
        5. SMEAR Microscopy
          1. By Value
        6. Cultured-Based Tests
          1. By Value
        7. Radiography Tests
          1. By Value
        8. Others
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Diagnostic Laboratories
          1. By Value
        3. Physician’s Office Laboratories
          1. By Value
        4. Reference Laboratories
          1. By Value
        5. Academics and Research Facilities
          1. By Value
    5. Canada
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Nucleic Acid Testing (NAT)
        1. By Value
      3. Skin Test / Mantoux Test (TST)
        1. By Value
      4. Blood Test / Serology Test
        1. By Value
      5. SMEAR Microscopy
        1. By Value
      6. Cultured-Based Tests
        1. By Value
      7. Radiography Tests
        1. By Value
      8. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Physician’s Office Laboratories
        1. By Value
      4. Reference Laboratories
        1. By Value
      5. Academics and Research Facilities
        1. By Value
    4. U.K.
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Nucleic Acid Testing (NAT)
          1. By Value
        3. Skin Test / Mantoux Test (TST)
          1. By Value
        4. Blood Test / Serology Test
          1. By Value
        5. SMEAR Microscopy
          1. By Value
        6. Cultured-Based Tests
          1. By Value
        7. Radiography Tests
          1. By Value
        8. Others
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Diagnostic Laboratories
          1. By Value
        3. Physician’s Office Laboratories
          1. By Value
        4. Reference Laboratories
          1. By Value
        5. Academics and Research Facilities
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Nucleic Acid Testing (NAT)
        1. By Value
      3. Skin Test / Mantoux Test (TST)
        1. By Value
      4. Blood Test / Serology Test
        1. By Value
      5. SMEAR Microscopy
        1. By Value
      6. Cultured-Based Tests
        1. By Value
      7. Radiography Tests
        1. By Value
      8. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Physician’s Office Laboratories
        1. By Value
      4. Reference Laboratories
        1. By Value
      5. Academics and Research Facilities
        1. By Value
    4. China
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Nucleic Acid Testing (NAT)
          1. By Value
        3. Skin Test / Mantoux Test (TST)
          1. By Value
        4. Blood Test / Serology Test
          1. By Value
        5. SMEAR Microscopy
          1. By Value
        6. Cultured-Based Tests
          1. By Value
        7. Radiography Tests
          1. By Value
        8. Others
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Diagnostic Laboratories
          1. By Value
        3. Physician’s Office Laboratories
          1. By Value
        4. Reference Laboratories
          1. By Value
        5. Academics and Research Facilities
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Nucleic Acid Testing (NAT)
        1. By Value
      3. Skin Test / Mantoux Test (TST)
        1. By Value
      4. Blood Test / Serology Test
        1. By Value
      5. SMEAR Microscopy
        1. By Value
      6. Cultured-Based Tests
        1. By Value
      7. Radiography Tests
        1. By Value
      8. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Physician’s Office Laboratories
        1. By Value
      4. Reference Laboratories
        1. By Value
      5. Academics and Research Facilities
        1. By Value
    4. UAE
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Nucleic Acid Testing (NAT)
          1. By Value
        3. Skin Test / Mantoux Test (TST)
          1. By Value
        4. Blood Test / Serology Test
          1. By Value
        5. SMEAR Microscopy
          1. By Value
        6. Cultured-Based Tests
          1. By Value
        7. Radiography Tests
          1. By Value
        8. Others
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Diagnostic Laboratories
          1. By Value
        3. Physician’s Office Laboratories
          1. By Value
        4. Reference Laboratories
          1. By Value
        5. Academics and Research Facilities
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Nucleic Acid Testing (NAT)
        1. By Value
      3. Skin Test / Mantoux Test (TST)
        1. By Value
      4. Blood Test / Serology Test
        1. By Value
      5. SMEAR Microscopy
        1. By Value
      6. Cultured-Based Tests
        1. By Value
      7. Radiography Tests
        1. By Value
      8. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Physician’s Office Laboratories
        1. By Value
      4. Reference Laboratories
        1. By Value
      5. Academics and Research Facilities
        1. By Value
    4. Brazil
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Nucleic Acid Testing (NAT)
          1. By Value
        3. Skin Test / Mantoux Test (TST)
          1. By Value
        4. Blood Test / Serology Test
          1. By Value
        5. SMEAR Microscopy
          1. By Value
        6. Cultured-Based Tests
          1. By Value
        7. Radiography Tests
          1. By Value
        8. Others
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Diagnostic Laboratories
          1. By Value
        3. Physician’s Office Laboratories
          1. By Value
        4. Reference Laboratories
          1. By Value
        5. Academics and Research Facilities
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. TB Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Thermo Fisher Scientific Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Becton Dickinson and Company
    3. Hoffmann-La Roche Ltd.
    4. Qiagen NV
    5. Hologic Inc.
    6. BioMerieux SA
    7. Oxford Immunotec Ltd.
    8. Cepheid Inc.
    9. Akonni Biosystems Inc.
    10. PAR Pharmaceuticals
    11. Alere Inc. (Abbott)
    12. Lionex GmbH
    13. Creative Diagnostics
    14. Hain Life Science.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer
Straits Research - Access Portal
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Get Free Sample


We are featured on :

www.straitsresearch.com
© Copyright . All rights Reserved.